Linguamatics and Dow Jones partner to accelerate pharma industry research


Pharmaceutical companies can now extract competitive intelligence from Dow Jones Factiva content using Linguamatics advanced NLP-based text analytics.

Add This Share Buttons

Market leading NLP text analytics provider Linguamatics today announced a partnership with premium news content provider Dow Jones. The agreement allows pharmaceutical companies to extract key insights from Dow Jones Factiva utilizing Linguamatics I2E text mining technology.

The Linguamatics I2E platform is currently used by 18 of the top 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership helps users to derive key insights from Factiva content by leveraging advanced NLP to identify and extract critical concepts in a structured format for review and quick analysis. I2E eliminates the need for users to manually read through large quantities of documents to search for critical information. Instead, I2E rapidly connects relevant facts and relationships in a way that synthesizes knowledge and creates actionable insights.

“In order to stay on top of current market activity, industry mergers and acquisitions, and emerging technologies and trends, pharma companies have traditionally dedicated significant time and resources reviewing biomedical and patent literature, press releases and general news sources,” said Phil Hastings, Chief Business Development Officer at Linguamatics. “Our partnership with Dow Jones helps organizations to gain maximum value from the wealth of data provided by Factiva, speeding high quality insights.”

Under the terms of the agreement, Linguamatics customers who have text mining rights to Dow Jones Factiva can utilize the I2E platform to rapidly identify and extract relevant data. Users can apply preconfigured queries based on common use cases, or easily create their own queries based on their organization’s specific requirements.

“Pharmaceutical companies require a tremendous amount of current and historical industry information to ensure they remain abreast of ever-changing market conditions and the latest product innovations,” said Jason Malatesta, Head of Partnerships at Dow Jones. “Dow Jones has vast archives and real time streams of fully licensed premium news and data resources. By using Linguamatics’ advanced NLP text mining capabilities, organizations can quickly search and mine our content to advance their efforts to deliver life-enhancing and saving products.”

Dow Jones Factiva includes content from nearly 33,000 premium, licensed sources, as well as information on more than 20 million public and private companies.


About Linguamatics

Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support, Linguamatics’ solutions are used by top commercial, academic and government organizations, including 18 of the top 20 global pharmaceutical companies, and leading US healthcare organizations.

Linguamatics I2E is used to mine a wide variety of text resources, such as scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds, social media and proprietary content. I2E can be deployed as an in-house enterprise system, or as Software-as-a-Service (SaaS) on the cloud. For more information, visit and follow @Linguamatics on Twitter.


Linguamatics Media contact:

Michelle Ronan Noteboom, Sr. Account Director

Amendola Communications

+ 1 512.426.2870  



Linguamatics is the world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support.